Evolocumab Added to Statins to Reduce Progression of Coronary Atherosclerosis

JAMA. 2017 Apr 25;317(16):1690. doi: 10.1001/jama.2017.3440.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticholesteremic Agents / therapeutic use
  • Atherosclerosis / drug therapy
  • Coronary Artery Disease / drug therapy*
  • Disease Progression
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*

Substances

  • Anticholesteremic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors